Retatrutide has emerged as a new treatment in the fight against obesity. This revolutionary drug, classified as a dual GLP-1 and GIP receptor agonist, exhibits promising results in clinical trials. By stimulating https://miriamdxlu474433.slypage.com/36888834/retatrutide-a-promising-new-treatment-for-obesity